分子细胞遗传学市场规模、份额、成长分析、按产品、按技术、按应用、按最终用户、按地区 - 产业预测，2024-2031 年

2022年分子细胞遗传学的全球市场规模估值为23.7亿美元，从2023年的25.8亿美元增长到2031年的50.2亿美元，并预计在预测期内增长（2024-预计复合年增长率为8.7 ） 2031 年的百分比）。

分子细胞遗传学领域整合了分子生物学和细胞遗传学，其基础知识是正常人体细胞有 46 条染色体发挥重要作用。该领域专注于透过萤光杂合反应(FISH) 等技术研究染色体异常，以帮助检测和治疗各种癌症，包括脑肿瘤和骨髓恶性肿瘤。由于癌症、遗传疾病和人口老化的日益流行，该市场正在经历显着增长。此外，医疗保健技术的进步，包括标靶治疗的广泛使用以及试剂和软体的改进，也有助于提高诊断准确性。生物医学研究投资的增加进一步推动了市场扩张，并预示着分子细胞遗传学的强劲未来。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究
• 专利分析

分子细胞遗传学市场规模：依产品

• 市场概况
• 试剂套件和试剂
  • 检测套组
  • 探测
  • 萤光和试剂
  • 其他套件和试剂
• 装置
• 消耗品
• 软体和服务

分子细胞遗传学市场规模：依技术分类

• 市场概况
• 比较杂合反应
  • 基于晶片的比较基因组杂合反应
  • 标准比较杂合反应
• 萤光原位杂合技术
• 显色原位杂交
• 核型分析
  • 频谱
  • 虚拟的
• 其他技术

分子细胞遗传学市场规模：依应用分类

• 市场概况
• 遗传疾病
• 癌症
• 个人化医疗
• 其他用途

分子细胞遗传学市场规模：依最终用户分类

• 市场概况
• 临床研究室
• 医院及病理实验室
• 学术研究所
• 製药和生物技术公司
• 其他最终用户

分子细胞遗传学市场规模：按地区

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• F. Hoffmann-la roche ltd.
• Agilent technologies, inc.
• Abbott laboratories
• Thermo fisher scientific, inc.
• Illumina inc.
• Revvity
• Pacific biosciences
• Bio-rad laboratories, inc.
• Bio-techne corporation
• Genedx
• Bioview
• Applied spectral imaging, inc.
• Cytotest inc.
• Kromatid, inc.
• Genial genetic solutions ltd.
• Cytognomix, inc.
• Metasystems
• Scigene
• Biomodal
• Biocare medical

结论和建议

Global Molecular Cytogenetics Market size was valued at USD 2.37 billion in 2022 and is poised to grow from USD 2.58 billion in 2023 to USD 5.02 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).

The field of molecular cytogenetics, integrating molecular biology and cytogenetics, plays a crucial role in distinguishing healthy cells from cancerous ones, stemming from the foundational knowledge that normal human cells contain 46 chromosomes. This discipline aids in the detection and treatment of various cancers, including brain tumors and hematological malignancies, focusing on chromosomal abnormalities through techniques like fluorescence in situ hybridization (FISH). The market is witnessing significant growth, driven by the increasing prevalence of cancer, genetic disorders, and an aging population. Additionally, the rising adoption of targeted therapies and advancements in healthcare technology, including improved reagents and software, contribute to enhanced diagnostic accuracy. Increased investment in biomedical research further propels market expansion, projecting a robust future for molecular cytogenetics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Molecular Cytogenetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Molecular Cytogenetics Market Segmental Analysis

Global Molecular Cytogenetics Market is segmented by product, technique, application, end user and region. Based on product, the market is segmented into kits & reagents, instruments, consumables and software & services. Based on technique, the market is segmented into comparative genomic hybridization, fluorescence in-situ hybridization, chromogenic in-situ hybridization, karyotyping and other techniques. Based on application, the market is segmented into genetic disorders, cancer, personalized medicine and other applications. Based on end user, the market is segmented into clinical & research laboratories, hospitals & path labs, academic research institutes, pharmaceutical & biotechnology companies and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Molecular Cytogenetics Market

The Global Molecular Cytogenetics market is poised for significant growth, driven primarily by the rising incidence of cancer cases worldwide. This field, which merges the principles of cytogenetics with molecular biology, is expected to see increased adoption as more healthcare professionals recognize its efficacy in diagnosing and understanding various cancers. The growing prevalence of cancer not only highlights the need for advanced diagnostic tools but also encourages investments and research in molecular cytogenetics, thereby fueling market expansion. As a result, the demand for molecular cytogenetics will likely continue to rise throughout the projected period.

Restraints in the Global Molecular Cytogenetics Market

The Global Molecular Cytogenetics market faces several significant constraints that could impede its growth. Stringent regulatory requirements pose a challenge, as compliance can be both complex and time-consuming. Additionally, unfavorable reimbursement policies from insurance providers significantly limit access to molecular diagnostic tests, which are essential for early detection of genetic conditions. The high costs associated with these tests, typically ranging around USD 300 each, also create a financial barrier for many patients and healthcare providers. Collectively, these factors contribute to a restrictive environment that hampers the expansion of the molecular cytogenetics market.

Market Trends of the Global Molecular Cytogenetics Market

The Global Molecular Cytogenetics market is witnessing a robust growth trend, driven primarily by the increasing emphasis on personalized medicine and advanced therapeutic options in oncology. As genomic understanding becomes crucial for effective cancer care-enabling precise diagnostics, tailored treatment plans, and improved survival predictions-the demand for molecular cytogenetic techniques is surging. This market is expected to expand significantly as healthcare providers leverage these technologies for detailed cancer analysis and individualized therapies. As pharmacotherapy and bespoke treatment alternatives gain prominence, the market is poised for lucrative expansion throughout the forecast period, underlining the pivotal role of molecular cytogenetics in modern oncology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Patent Analysis

Global Molecular Cytogenetics Market Size by Product & CAGR (2024-2031)

• Market Overview
• Kits & Reagents
  • Testing Kits
  • Probes
  • Fluorescent Affinity Reagents
  • Other Kits & Reagents
• Instruments
• Consumables
• Software & Services

Global Molecular Cytogenetics Market Size by Technique & CAGR (2024-2031)

• Market Overview
• Comparative Genomic Hybridization
  • Array-Based Comparative Genomic Hybridization
  • Standard Comparative Genomic Hybridization
• Fluorescence In-Situ Hybridization
• Chromogenic In-Situ Hybridization
• Karyotyping
  • Spectral
  • Virtual
• Other Techniques

Global Molecular Cytogenetics Market Size by Application & CAGR (2024-2031)

• Market Overview
• Genetic Disorders
• Cancer
• Personalized Medicine
• Other Applications

Global Molecular Cytogenetics Market Size by End User & CAGR (2024-2031)

• Market Overview
• Clinical & Research Laboratories
• Hospitals & Path Labs
• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Other End Users

Global Molecular Cytogenetics Market Size & CAGR (2024-2031)

• North America (Product, Technique, Application, End User)
  • USA
  • Canada
• Europe (Product, Technique, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technique, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technique, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technique, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffmann-la roche ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent technologies, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo fisher scientific, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-rad laboratories, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-techne corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioview
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied spectral imaging, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytotest inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kromatid, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genial genetic solutions ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytognomix, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metasystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scigene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomodal
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations